Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


Social Media in the Pharmaceutical Industry

23 Jan 2013 - 24 Jan 2013 - London, UK



Bookmark and Share


Connectivity, Engagement and Implementation

Sponsored by: greater than one

Book by 28th September and receive a £300 discount

Visit www.social-media-pharma.com to claim your discount!

SMi Group is proud to present the 5th conference in their highly successful series of Social Media in the Pharmaceutical Industry this January that will allow companies to focus on how to improve their existing social media strategies, how to innovate into the new and emerging techniques and technologies and enhancing their company’s engagement potential. We are excited to also feature talks from key companies in the industry, including Google, Pfizer, UCB Pharma and Bayer, and will focus on case studies from the industry, techniques for social media use and implementation of social media mechanisms. 

Key reasons to attend include:

Speak with the key opinion leaders of the industry about the future of social media, digital pharma, e-marketing and regulations

Hear about the case studies in the industry: how the affected those involved, how they were successful and the reasons that they were unsuccessful

Learn about crisis management, adaptations and risk management in unsuccessful campaigns, and apply them to your own company’s

Discuss the latest technologies in social media with companies that create them, and debate their benefits and difficulties with those companies that utilise them

Put forward problems and difficulties of your own, and discuss potential solutions and action plans for the future

Expert Key speakers include:

Beat Buehlmann, Industry Leader Healthcare UK, Google Inc

Trish Nettleship, Director, Social Media & Influence, UCB Pharma

 • Rahul Agrawal, Global Director, Clinical Development and Strategic 

Marketing, Bayer Healthcare

Andrew Widger, Director, Media Relations EMEA Pfizer Inc

Josep Picas, President, European Association of Healthcare IT Managers


Contact Fateja Begum on tel +44 0 207 827 6184 or email fbegum@si-online.co.uk 





Further information
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!